Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.92 -0.02 (-1.04%)
As of: Oct 22, 2026 · 12:52 PM EDT

Polaryx Therapeutics (PLYX) Current Assets (2024 - 2026)

Updated

Polaryx Therapeutics' Current Assets was $11.81 million in Q2 2026, up 237.3% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Current Assets at Polaryx Therapeutics came in at $5.17 million, up 3.4% from FY2024.

  • In earlier years, Current Assets was $5 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,166.97 Bn 1,135.56 Bn 19.71 Bn 64.67 Bn
2 Johnson & Johnson 644.38 Bn 564.24 Bn 17.30 Bn 56.35 Bn
3 AbbVie 501.54 Bn 474.65 Bn 12.70 Bn 33.67 Bn
4 Merck 359.36 Bn 313.74 Bn 12.21 Bn 36.68 Bn
5 Novartis Ag 302.13 Bn 266.12 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 267.59 Bn 241.28 Bn 12.86 Bn 27.97 Bn
7 Amgen 241.49 Bn 196.89 Bn 7.24 Bn 34.96 Bn
8 Gilead Sciences 192.85 Bn 167.05 Bn 6.22 Bn 13.95 Bn
9 Pfizer 171.77 Bn 118.41 Bn 10.94 Bn 41.36 Bn
10 Polaryx Therapeutics 92.68 Mn 68.30 Mn - 11.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.81 Mn
Mar 31, 2026 3.50 Mn
Dec 31, 2025 5.17 Mn
Dec 31, 2024 5.00 Mn
API Access

Polaryx Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=PLYX&period=max&api_key=YOUR_API_KEY